Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX)

Historical Holders from Q1 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $.001 per share
Symbol
MBRX on Nasdaq
Shares outstanding
31,794,008
Price per share
$0.5300
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
778,273
Total reported value
$412,657
% of total 13F portfolios
0%
Share change
+345,621
Value change
+$243,573
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
24
Price from insider filings
$0.4970
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 5% -44% $618,743 +$131,243 1,586,521 +27% Armistice Capital, LLC 30 Jun 2025
As of 30 Sep 2025, Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) has 24 institutional shareholders filing 13F forms. They hold 778,273 shares. of 31,794,008 outstanding shares (2.4%) .

Institutional Holders of Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 778,273 $412,657 +$243,573 53% 24
2025 Q2 432,652 $130,873 -$1,202,127 30.2% 22
2025 Q1 1,478,032 $1,438,584 +$969,253 97.36% 21
2024 Q4 464,650 $789,917 +$6,231 170% 19
2024 Q3 460,563 $1,308,014 +$417,028 284% 17
2024 Q2 313,722 $1,103,728 +$117,821 352.01% 15
2024 Q1 444 $3,541 +$1,041 591.02% 3